306 studies found for:    Open Studies | "Alzheimer Disease"
Show Display Options
Rank Status Study
1 Recruiting Alzheimer's Disease Genetics Study
Conditions: Alzheimer Disease;   Late Onset Alzheimer Disease;   Dementia
Intervention:
2 Recruiting Sleep Apnea in Early to Mid-Stage Alzheimer's Disease
Conditions: Early Onset Alzheimer Disease;   Alzheimer Disease;   Obstructive Sleep Apnea Syndromes
Interventions: Device: CPAP Treatment;   Device: No treatment
3 Recruiting Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
Conditions: Alzheimers Disease;   Dementia;   Alzheimers Disease, Familial
Interventions: Drug: Gantenerumab;   Drug: Solanezumab;   Drug: Matching Placebo (Gantenerumab);   Drug: Matching Placebo (Solanezumab)
4 Recruiting MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
Condition: Alzheimer Disease
Interventions: Drug: RO4602522;   Drug: RO4601522;   Drug: placebo;   Drug: donepezil;   Drug: rivastigmine;   Drug: galantamine;   Drug: memantine
5 Unknown  Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids
Conditions: Alzheimer Disease;   Presbycusis
Intervention: Device: Hearing aids used : PHONAK Savia and Valeo
6 Recruiting Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls
Conditions: Parkinson Disease;   Alzheimer Disease
Intervention: Drug: [18F] CFPyPB
7 Not yet recruiting Differential Effects of Various Anesthetic Agents on Cognitive Function in Patients With Alzheimer's Disease
Condition: Alzheimer Disease
Intervention:
8 Unknown  Pilot Study of the Effects of Resveratrol Supplement in Mild-to-Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Dietary Supplement: Longevinex brand resveratrol supplement;   Dietary Supplement: placebo
9 Recruiting Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: AADvac1
10 Not yet recruiting Isolated Erythrocyte Membrane Susceptibility to Photo-oxidative Stress in Alzheimer's Disease
Conditions: Alzheimer Disease;   Oxidative Stress;   Adrenocortical Hyperfunction
Intervention:
11 Recruiting ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Device: DBS-f on;   Device: DBS-f off
12 Unknown  Alzheimer`s Disease Acitretin Medication
Condition: Alzheimer Disease
Interventions: Drug: Acitretin;   Drug: Placebo
13 Recruiting A Study to Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's Disease
Conditions: Healthy;   Alzheimer Disease
Interventions: Procedure: Standard CSR sampling procedure;   Procedure: Alternate frequency CSR sampling procedure;   Procedure: Standard frequent CSR sampling procedure with 800 mg ibuprofen;   Procedure: Alternative lower frequency CSR sampling procedure
14 Recruiting A Study of LY3002813 in Participants With Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Biological: LY3002813-IV;   Biological: LY3002183-SC;   Drug: Placebo-IV
15 Recruiting Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: LY2886721;   Drug: Placebo
16 Recruiting Alzheimer Disease : Rehabilitation's Intervention at Home
Condition: Alzheimer's Disease
Intervention: Behavioral: Home rehabilitation therapy
17 Recruiting Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention:
18 Recruiting Alzheimer's Disease, Caregiving, and Social Networks
Condition: Alzheimer's Disease
Intervention:
19 Recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237 200 mg/day;   Drug: Placebo
20 Recruiting Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease
Condition: Alzheimer's Disease
Interventions: Drug: Epigallocatechin-Gallate;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years